Anne Fournier

Anne Fournier

Auto-generated profile, based on publicly available information

Anne Fournier

Service of Pharmacy, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
AFA. Fournier
A. Fournier
PEP. Eggimann
P. Eggimann
OPO. Pantet
O. Pantet
JPJ. L. Pagani
J. L. Pagani
EDE. Dupuis-Lozeron
E. Dupuis-Lozeron
YQYok-Ai Que
Yok-Ai Que
As pharmacokinetics after burn trauma are difficult to predict, we conducted a 3-year prospective, monocentric, randomized, controlled trial to determine the extent of under- and overdosing of antibiotics and further evaluate the impact of systematic therapeutic drug monitoring (TDM) with same-day real-time dose adaptation to reach and maintain antibiotic concentrations within the therapeutic range. Forty-five consecutive burn patients treated with antibiotics were prospectively screened. Forty fulfilled the inclusion criteria; after one patient refused to participate and one withdrew consent, 19 were randomly assigned to an intervention group (patients with real-time antibiotic concentration determination and subsequent adaptations) and 19 were randomly assigned to a standard-of-care group (patients with antibiotic administration at the physician's discretion without real-time TDM). Seventy-three infection episodes were analyzed. Before the intervention, only 46/82 (56%) initial trough concentrations fell within the range. There was no difference between groups in the initial trough concentrations (adjusted hazard ratio = 1.39 [95% confidence interval {CI}, 0.81 to 2.39], P = 0.227) or the time to reach the target. However, thanks to real-time dose adjustments, the trough concentrations of the intervention group remained more within the predefined range (57/77 [74.0%] versus 48/85 [56.5%]; adjusted odd ratio [OR] = 2.34 [95% CI, 1.17 to 4.81], P = 0.018), more days were spent within the target range (193 days/297 days on antibiotics [65.0%] versus 171 days/311 days in antibiotics [55.0%]; adjusted OR = 1.64 [95% CI, 1.16 to 2.32], P = 0.005), and fewer results were below the target trough concentrations (25/118 [21.2%] versus 44/126 [34.9%]; adjusted OR = 0.47 [95% CI, 0.26 to 0.87], P = 0.015). No difference in infection outcomes was observed between the study groups. Systematic TDM with same-day real-time dose adaptation was effective in reaching and maintaining therapeutic antibiotic concentrations in infected burn patients, which prevented both over- and underdosing. A larger multicentric study is needed to further evaluate the impact of this strategy on infection outcomes and the emergence of antibiotic resistance during long-term burn treatment. (This study was registered with the ClinicalTrials.gov platform under registration no. NCT01965340 on 27 September 2013.)

20 November 2023 in Annales Pharmaceutiques Françaises
Verified
Journal Article
Closed access
AFA. Fournier
A. Fournier
CFC. Fallet
C. Fallet
FSF. Sadeghipour
F. Sadeghipour
NPN. Perrottet
N. Perrottet

13 October 2020 in Drugs & Aging
Verified
Journal Article
Closed access
PDF file
AFAnne Fournier
Anne Fournier
PAPauline Anrys
Pauline Anrys
JBJean-Baptiste Beuscart
Jean-Baptiste Beuscart
ODOlivia Dalleur
Olivia Dalleur
SHSéverine Henrard
Séverine Henrard
ASAnne Spinewine
Anne Spinewine

1 September 2018 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
AFAnne Fournier
Anne Fournier
SGSylvain Goutelle
Sylvain Goutelle
YQYok-Ai Que
Yok-Ai Que
PEPhilippe Eggimann
Philippe Eggimann
OPOlivier Pantet
Olivier Pantet
CCChantal Csajka
Chantal Csajka
The objective of this study was to investigate the population pharmacokinetics (PK) of amoxicillin in ICU burn patients and the optimal dosage regimens. This was a prospective study involving 21 consecutive burn patients receiving amoxicillin.

27 November 2017 in Paediatrics & Child Health
Verified
Journal Article
Open access
PDF file
MNMichael Narvey
Michael Narvey
KWKenny K Wong
Kenny K Wong
AFAnne Fournier
Anne Fournier
Pulse oximetry screening is safe, noninvasive, easy to perform and proven to enhance detection of critical congenital heart disease in newborns. However, this test has yet to be adopted as routine practice in Canada. The present practice point highlights essential details and recommendations for screening, which research has shown to be highly specific, with low false-positive rates. Optimal screening for critical congenital heart disease should include prenatal ultrasound, physical examination and pulse oximetry screening. Screening should be performed between 24 hours and 36 hours postbirth, using the infant’s right hand and either foot to minimize false-positive results. Newborns with abnormal results should undergo a thorough evaluation by the most responsible health care provider. When a cardiac diagnosis cannot be excluded, referral to a paediatric cardiologist for consultation and echocardiogram is advised.

19 July 2022 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
MPMelissa Pitton
Melissa Pitton
SOSimone Oberhaensli
Simone Oberhaensli
FAFiona Appiah
Fiona Appiah
JPJean-Luc Pagani
Jean-Luc Pagani
AFAnne Fournier
Anne Fournier
DCDavid R. Cameron
David R. Cameron
Pseudomonas aeruginosa is a major pathogen in burn wound infections. We present one of the first reports of small-colony variant (SCV) emergence of P. aeruginosa , taken from a patient under aminoglycosides for a persistent burn wound infection. We confirm the causative role of a single ispA mutation in SCV emergence and increased aminoglycoside resistance. IspA is involved in the synthesis of ubiquinone, providing a possible link between electron transport and SCV formation in P. aeruginosa .